Epoprostenol Uses, Dosage, Side Effects and Interactions
Flolan
Flolan was the first epoprostenol product the FDA approved, in September 1995. The FDA now lists it as discontinued; generic epoprostenol is still listed.
Veletri
Veletri came 12 years after Flolan (June 2008) as an injection. An FDA-approved generic with the same active ingredient is listed.
Epoprostenol is a prostacyclin vasodilator given by intravenous infusion to treat pulmonary arterial hypertension (PAH) and improve exercise capacity.
Quick links
Ask Anything About EpoprostenolType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Epoprostenol in Short
- Drug class Prostacycline Vasodilator How the FDA classifies it
What it treatsEpoprostenol treats pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of the lungs (WHO Group 1). It is used to improve exercise capacity. Both Veletri and Epoprostenol for injection carry this use.
- How you get it Prescription only
- Comes asInjection (into a vein)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs136 interact 4 major, 111 moderate and 21 minor
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Epoprostenol (Flolan, Veletri) is a specialist medicine for more advanced pulmonary arterial hypertension (PAH, high blood pressure in the lung arteries). It is a prostacyclin vasodilator that widens the lung arteries and keeps platelets from clumping, in use since about 1995, with FDA-approved generic versions listed. Side effects are common but usually manageable, most often flushing, headache, jaw pain and nausea, and they tend to flare after each dose increase. The one thing to guard against is the infusion stopping, since even a brief interruption from a pump, line or supply problem can bring on rebound pulmonary hypertension, with shortness of breath, dizziness and weakness.
Key Takeaways From the HelloPharmacist Team
- Expect it to run nonstop through a permanent IV line and small portable pump, which you learn to mix and manage at home.
- Keep a backup pump and spare supplies with you, and get help right away if the pump or line fails.
- Use sterile technique with the catheter every time, and call promptly about fever, chills, or redness or pain at the site.
- Let your PAH team raise the rate gradually over time, and never adjust or pause it yourself, even when side effects flare.
Patient Information Guide for Epoprostenol
What It’s Used For
Epoprostenol is used for one main condition.
- Pulmonary arterial hypertension (PAH, WHO Group 1), to improve exercise capacity (Veletri, intravenous)
- Pulmonary arterial hypertension (PAH, WHO Group 1), to improve exercise capacity (Epoprostenol for injection, intravenous)
- Studies were mostly in people with NYHA Class III–IV symptoms, with idiopathic or heritable PAH or PAH linked to connective tissue diseases
How It Works
Epoprostenol is a prostacyclin vasodilator. It directly widens arteries in the lungs and the rest of the body. It also blocks platelet clumping.
Opening up the lung arteries is why it helps in PAH.
Drug Class
Drug Class
- Prostacycline Vasodilator
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Prostacycline Vasodilator
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Epoprostenol in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Vasodilation
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Prostaglandins I
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Platelet aggregation inhibitors excl. heparin
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Epoprostenol is a continuous intravenous infusion, usually through a central venous catheter and a portable pump. Your team starts low and raises the rate step by step based on your symptoms and side effects.
It is not taken by mouth, so food does not matter.
- Reconstitute only as directed, and do not mix with other medicines or solutions.
- Never stop abruptly or reduce the dose suddenly.
- Rate changes should be made only under a doctor's direction, except in life-threatening emergencies.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Pulmonary arterial hypertension (high blood pressure in the lung arteries)
Adults · Starting dose Initiate at 2 ng/kg/min and increase in increments of 2 ng/kg/min every 15 minutes or longer until a tolerance limit to the drug is established or further increases are not clinically warranted; if 2 ng/kg/min is not tolerated, use a lower dose
Good to know
Given by continuous intravenous infusion via a central venous catheter; peripheral infusion may be used temporarily until central access is established
Adults · Dose increase Adjust the infusion by 1- to 2-ng/kg/min increments at intervals of at least 15 minutes sufficient to allow assessment of clinical response; in clinical trials increases occurred at intervals of 24 to 48 hours or longer
Good to know
Monitor standing and supine blood pressure and heart rate for several hours after a new rate
Adults · Dose decrease Decrease gradually in 2-ng/kg/min decrements every 15 minutes or longer until the dose-limiting effects resolve
Good to know
Avoid abrupt withdrawal or sudden large reductions in infusion rates
Side Effects
Many side effects come from the drug widening blood vessels.
Common side effects
- Flushing
- Headache
- Nausea and vomiting
- Diarrhea
- Jaw pain
- Low blood pressure
- Anxiety or nervousness
- Flu-like symptoms
When to get medical help
- Get help right away if your infusion is interrupted or the pump or line fails. Symptoms like shortness of breath, dizziness or weakness can signal rebound pulmonary hypertension.
- Call your doctor about signs of infection at the catheter site or in the bloodstream, such as fever, chills, redness or pain.
- Seek help for fainting, severe dizziness or very low blood pressure.
- Report unusual bleeding or bruising.
- Seek urgent care for new or worsening shortness of breath, which can be a sign of fluid in the lungs (pulmonary edema).
- Call your care team right away if the pump delivers too much or too little medicine.
Act quickly on signs of catheter infection, bleeding, fainting, or worsening breathing. Pump or delivery problems can also cause symptoms of too much or too little drug.
Warnings and Precautions
- Do not stop suddenly. Interruptions can cause rebound pulmonary hypertension and have been linked to a death in trials.
- Start treatment where monitoring and emergency care are available.
- Catheter-related infection and sepsis (a serious bloodstream infection) can occur, so use aseptic technique.
- Blood thinners are generally given unless contraindicated, to reduce clot risk.
- Treatment may be needed for years.
Interactions
Some medicines can add to epoprostenol's effects.
- Diuretics, blood pressure medicines and other vasodilators: further blood pressure drops
- Antiplatelet drugs or anticoagulants: possible higher bleeding risk
- Digoxin: levels may rise, which matters if you are prone to digoxin toxicity
Interactions Listed in the FDA-Approved Label
From the Epoprostenol prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Diuretics, antihypertensive agents, or other vasodilatorsWhat happensAdditional reductions in blood pressure may occur.
-
Antiplatelet agents or anticoagulantsWhat happensEpoprostenol may increase the risk of bleeding, although patients in clinical trials were maintained on anticoagulants without evidence of increased bleeding.
-
What happensDigoxin concentrations may be elevated after starting epoprostenol (apparent oral clearance decreased by 15% on the second day), which may be clinically significant in patients prone to digoxin toxicity.
-
What happensApparent oral clearance of furosemide decreased by 13% on the second day of therapy and returned to baseline by day 87; not likely to be clinically significant.
Read the label’s full interactions text
7 DRUG INTERACTIONS Additional reductions in blood pressure may occur when epoprostenol for injection is administered with diuretics, antihypertensive agents, or other vasodilators. When other antiplatelet agents or anticoagulants are used concomitantly, there is the potential for epoprostenol for injection to increase the risk of bleeding. However, patients receiving infusions of epoprostenol in clinical trials were maintained on anticoagulants without evidence of increased bleeding. In clinical trials, epoprostenol was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen. In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with epoprostenol was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87. The change in furosemide clearance value is not likely to be clinically significant. However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with epoprostenol, which may be clinically significant in patients prone to digoxin toxicity. · Diuretics, antihypertensive agents, or other vasodilators: reduction in blood pressure · Antiplatelet agents or anticoagulants: increase the risk of bleeding · Patients on digoxin: elevations of digoxin concentrations clinically significant in patients prone to digoxin toxicity
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Not for long-term use with congestive heart failure due to severe left ventricular systolic dysfunction.
- Not for long-term use if pulmonary edema developed during dose start.
- Not for people with known hypersensitivity to it or similar compounds.
- Pregnancy: data are limited and have not established a risk; untreated PAH poses risks to mother and baby.
- Breastfeeding: no data; weigh benefits and risks with your doctor.
- Children: safety and effectiveness not established.
- Older adults: cautious dosing, usually starting low.
Overdose
Too much epoprostenol causes exaggerated effects such as flushing, headache, low blood pressure, fast heartbeat, nausea, vomiting and diarrhea. Treatment usually means lowering the dose. Fatal cases of low oxygen, low blood pressure and respiratory arrest have been reported after overdose, so seek urgent help if you suspect a delivery error.
Half-Life and How Your Body Processes It
Epoprostenol breaks down very quickly in the blood. Its half-life in humans is expected to be no more than about 6 minutes. This is why even short interruptions can cause symptoms. It is extensively metabolized, and most of it leaves in the urine.
Storage
Unopened vials of VELETRI are stable until the date indicated on the package when stored at 68° to 77°F (20° to 25°C).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Epoprostenol
From the licensed clinical database we use, rolled up per supplement, most serious first.136 supplements and herbal products have documented interactions with Epoprostenol in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 4Major
- 111Moderate
- 21Minor
- ACTIVATED CHARCOALMajor
- AMERICAN HELLEBOREMajor
- AMERICAN MISTLETOEMajor
- TYRAMINEMajor
- ADRAFINILModerate
- AGMATINEModerate
- ALGAL OILModerate
- ANDROGRAPHISModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrients Epoprostenol May Deplete
Nutrients Epoprostenol has been linked with lower levels of, from the licensed clinical database we use.Epoprostenol has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.
Epoprostenol: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Epoprostenol — the kind of thing our pharmacy team would talk through with you at the counter.
What is epoprostenol used for?
Can I stop epoprostenol suddenly?
How is epoprostenol given?
What side effects should I expect?
Can I take epoprostenol with other medicines?
Is epoprostenol safe in pregnancy?
Is epoprostenol available over the counter?
When was epoprostenol first available?
Who makes epoprostenol?
What is the brand name of epoprostenol?
What is the generic name of Flolan?
What drug class is epoprostenol?
Is there a generic version of epoprostenol?
What strengths does epoprostenol come in?
Is there a epoprostenol shortage?
Where can I read the epoprostenol prescribing information (package insert)?
Is epoprostenol gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Epoprostenol
Skip the scrolling. Ask in your own words and get an answer from Epoprostenol’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Epoprostenol’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Epoprostenol on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Epoprostenol Forms and Strengths (How It Comes)
Epoprostenol comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Epoprostenol inactive ingredients by manufacturer.
Injection
How this form is used
- Veletri is used to treat pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity.
- Epoprostenol for injection is used to treat pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity.
- Veletri is given as a continuous intravenous infusion through a central venous catheter using an ambulatory pump.
- Epoprostenol for injection is given as a continuous intravenous infusion through a central venous catheter using an ambulatory pump.
- Veletri is reconstituted only with Sterile Water for Injection or Sodium Chloride 0.9% Injection and not mixed with other medicines.
- Epoprostenol for injection is reconstituted only with Sterile Water for Injection or Sodium Chloride 0.9% Injection and not mixed with other medicines.
Epoprostenol on the U.S. Market: Products, Makers and Brands
How Epoprostenol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
4 companies list 8 Epoprostenol product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 1995. The one brand name in the directory today is Veletri; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (6) · Unfinished injection, powder, lyophilized, for solution (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Epoprostenol Is Used (Medicaid Data)
How many Epoprostenol prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Epoprostenol prescribed? Of the 1,682 medications we measure, Epoprostenol ranks #1,291 by Medicaid prescriptions — more than 23% of them.
Utilization by Epoprostenol product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
epoprostenol 1.5 MG Injection
2 of 6 listed NDCs had Medicaid claims. RxNorm 562502
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 2 of the 6 listed Epoprostenol NDCs had Medicaid claims.
Compare Epoprostenol Products
A representative set of FDA-listed product records for Epoprostenol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 0.5 mg/10 mL | Intravenous | Actelion Pharmaceuticals US, Inc. | NDA | View NDC → |
| 1.5 mg/10 mL | Intravenous | Actelion Pharmaceuticals US, Inc. | NDA | View NDC → |
| 0.5 mg/10 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 1.5 mg/10 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 0.5 mg/10 mL | Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| 1.5 mg/10 mL | Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| 0.5 mg/10 mL | Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 1.5 mg/10 mL | Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
Showing 8 of 8 products — FDA National Drug Code Directory. See every product, package size and price: browse all 8 Epoprostenol NDCs →
Epoprostenol Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Epoprostenol — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Epoprostenol in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Epoprostenol FDA Approval History
How Epoprostenol went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Epoprostenol Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Epoprostenol recalls since July 2021.
✅No Epoprostenol recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Epoprostenol in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 2
- Forms in current FDA listings
- 1 of 1
RxCUI 8814 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Epoprostenol Supply and Shortage Status
Whether Epoprostenol is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Epoprostenol Brand Names
Epoprostenol has 2 brand names on record: Flolan and Veletri. Veletri is in the FDA’s product directory today; Flolan is not. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Epoprostenol: Manufacturers and Labelers
4 companies list Epoprostenol products with the FDA. By number of product records, the largest are Actelion Pharmaceuticals US, Inc., Gland Pharma Limited, Mylan Institutional LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Epoprostenol Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Actelion Pharmaceuticals US, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →